Latest investigator Stories
To help manufacturers better understand the final guidance “Circumstances that Constitute Delaying, Denying, Limiting, or Refusing to Permit Drug Inspection,” FDAnews has engaged FDA inspections
Additional Data Analysis Showed Every Two Week and Monthly Dosing Regimens of Evolocumab Were Clinically Equivalent THOUSAND OAKS, Calif., Nov.
Each week FDAnews reporters spend hours talking to the quality managers at recently inspected facilities, surveying them about what happened during the inspection and what caught them by surprise.
- AIMing to establish a new treatment for ophthalmologic diseases - TOKYO, Oct. 14, 2014 /PRNewswire/ -- Astellas Pharma Inc.
FALLS CHURCH, Va., Sept. 12, 2014 /PRNewswire-iReach/ -- 9(th) Annual FDA Inspections Summit **Presented by FDAnews** Oct.
In four hours, John Avellanet delivers proven, practical techniques for fast, flexible, flawless inspectional handling and response.
The Foundation for Physical Therapy Board of Trustees recently awarded a total of $250,500 in Promotion of Doctoral Studies (PODS) I & II Scholarships and a New Investigator Fellowship Training
NEW YORK, June 10, 2014 /PRNewswire/ -- Intralinks® Holdings, Inc. (NYSE: IL), a leading, global SaaS provider of inter-enterprise
Subject Matter Experts (SMEs) need training and rehearsing to fine-tune their FDA investigator playbook.
LONDON, May 27, 2014 /PRNewswire/ -- Novartis, Janssen, Merck (known as MSD outside the United States and Canada), Lilly, and Pfizer have joined together with DrugDev in